Bet hedging for combinations of cancer drugs; assume the undetectable resistance mutations are there and treat anyway

Excel has its charm, but when stakes are high and data is paramount, a purpose-built database is the key to unlocking the full potential of your biomarker insights

Identifying the right biomarker to inform dose selection is critical, and with first in class agents there are always going to be unknowns.